Trametinib (DMSO solvate)
Trametinib (DMSO solvate), also known as GSK1120212, is a highly potent and selective allosteric inhibitor of MEK1 and MEK2 kinases with an IC50 of 2 nM. It is widely used in both in vitro and in vivo cancer research, particularly for studying the MAPK/ERK pathway in melanoma, NSCLC, and other malignancies.
Product Specifications
CAS Number
1187431-43-1
Product Name Alternative
Type, Trametinib, Trametinib (DMSO solvate), Trametinib dimethyl sulfoxide, Trametinib DMSO solvate, JTP74057, JTP-74057, JTP-74057 (DMSO solvate), JTP 74057, inhibit, Mitogen-activated protein kinase kinase, orally, Inhibitor, MEK1/2, MEK, MAPKK, MAP2K, GSK 1120212, GSK1120212, GSK-1120212, GSK-1120212 (DMSO solvate), AIA, Adjuvant-induced, arthritis, Apoptosis, CIA, collageninduced, DMSO solvate
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.82% (May vary between batches)
Solubility
DMSO:1.3 mg/mL (1.87 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.44 mM)
Smiles
CS (C) =O.CC (=O) Nc1cccc (c1) -n1c2c (C) c (=O) n (C) c (Nc3ccc (I) cc3F) c2c (=O) n (C2CC2) c1=O
Molecular Formula
C28H29FIN5O5S
Molecular Weight
693.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV641803 1.0 µg DNA
FAM135A Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 44392066 1.0 µg DNA
SMAD1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details